StemCell Therapy

By Priyanka Sharma

New Delhi: In a first in India, the country's top medical research body is working to create an Indian Council of Medical Research (ICMR) vaccine portal, as a repository for all information related to vaccine development in India. The ICMR vaccine portal would be made public by the next week.

In the first stage, the ICMR vaccine portal will reflect the information on COVID-19 vaccine in India. However, with time, the web portal will be strengthened with data available for all the vaccines used to prevent various diseases.

"The Central government along with the ICMR is making all best efforts to combat coronavirus pandemic. Wearing masks, hand-hygiene and social distancing are preventive measures but at the same time vaccine development is another important aspect which will be updated on the ICMR vaccine portal," said Dr Panda.

The scientist added that the ICMR vaccine portal will be made public by the next week.

It may be noted that three COVID vaccine candidates are in India which are in different phases of the clinical study.

The first is--inactivated virus vaccine, which is the 'Bharat Biotech Vaccine', being developed in collaboration with Indian Council of Medical Research (ICMR).

Similarly, the second is a 'DNA vaccine' of pharma giant called Zydus Cadila.

According to the scientist, the ICMR vaccine portal will have sections like-COVID-19 vaccine, India's initiative, International Symposium and FAQ for the general public (which would be presented in regional language).

The vaccine portal will also fetch the information related to COVID-19 vaccine from the World Health Organisation (WHO) as available on their website.

So far, India has reported 29,75,702 coronavirus cases with 55,794 people died due to the infection. In the last 24 hours, the country has seen 69,878 cases and 945 deaths as per the Union Health Ministry data.

Go here to read the rest:
Soon, India will have its dedicated vaccine portal: ICMR - ETHealthworld.com

This entry was posted on August 24, 2020 at 9:58 pm and is filed under Legal Issues Genetic Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |